Combining Chemoradiotherapy With Sintilimab in First-Line ICC
Combining Chemoradiotherapy With Sintilimab in First-Line ICC
Not yet recruiting · NCT06447454 · Registry updated 2024-06-07Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Combining Chemoradiotherapy With Sintilimab in First-Line ICC | intrahepatic cholangiocarcinoma | Not yet recruiting | Not stated | 2024-06-07 | NCT06447454 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Shanghai Zhongshan Hospital | 347 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Zhongshan Hospital | Shanghai | China | 7 |